Credit Suisse’s Pulse Biosciences PLSE Stock Holding History

Credit Suisse’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7	Closed	–	–	4221
2022 Q2	$0	Buy	+7	New	+$18	﹤0.01%	4217

Other funds holding PLSE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse's PLSE Position: Q3 2022 in Review

Credit Suisse sold out of Pulse Biosciences (PLSE) in Q3 2022, closing a stake of 7 shares.

Credit Suisse first reported a position in PLSE in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 31 funds tracked by Wall St. Rank hold PLSE as of Q3 2022.

Credit Suisse reported no remaining Pulse Biosciences position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 7 Pulse Biosciences shares in Q3 2022.
Credit Suisse first reported a position in Pulse Biosciences in Q2 2022 and held it in 1 quarter.
Credit Suisse's Pulse Biosciences position peaked at $0 in Q2 2022.
31 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.